Strategies to Overcome the Barrier of Ischemic Microenvironment in Cell Therapy of Cardiovascular Disease
The transplantation of various immune cell types are promising approaches for the treatment of ischemic cardiovascular disease including myocardial infarction (MI) and peripheral arterial disease (PAD). Major limitation of these so-called <i>Advanced Therapy Medicinal Products (ATMPs)</i>...
Main Authors: | Rouven Berndt, Martin Albrecht, René Rusch |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/5/2312 |
Similar Items
-
Platelet Contributions to Myocardial Ischemia/Reperfusion Injury
by: Nancy Schanze, et al.
Published: (2019-06-01) -
A Langendorff-perfused Mouse Heart Model for Delayed Remote Limb Ischemic Preconditioning Studies
by: Rohailla, Sagar
Published: (2012) -
A Langendorff-perfused Mouse Heart Model for Delayed Remote Limb Ischemic Preconditioning Studies
by: Rohailla, Sagar
Published: (2012) -
Disease-Modifying Antirheumatic Drugs and Remote Ischemic Postconditioning Ameliorate for Myocardial Injury in Rats Under Cerebral Stroke
by: Duygun Altıntaş Aykan, et al.
Published: (2019-11-01) -
Larger infarct size but equal protection by ischemic conditioning in septum and anterior free wall of pigs with LAD occlusion
by: Andreas Skyschally, et al.
Published: (2019-10-01)